Post job

Verastem Oncology CEO and executives

Executive Summary. Based on our data team's research, Brian M. Stuglik is the Verastem Oncology's CEO. Verastem Oncology has 150 employees, of which 27 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Verastem Oncology executive team is 33% female and 67% male.
  • 63% of the management team is White.
  • 8% of Verastem Oncology management is Hispanic or Latino.
  • 13% of the management team is Black or African American.
Work at Verastem Oncology?
Share your experience

Rate Verastem Oncology's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Brian M. Stuglik

CEO

Brian M. Stuglik's LinkedIn

Global leader in the oncology pharmaceutical sector having successfully developed, acquired and launched several multi-billion dollar oncology brands across multiple tumor types and therapeutic approaches. Over 3 decades of experience in US and International pharmaceutical development, product strategy, commercialization and business development; and, has cultivated an extensive network with specialists and companies developing new treatment approaches for patients living with cancer.

Recently, founded Proventus Health Solutions, a company specializing in helping oncology biotech companies create greater value by integrating development and commercial considerations into a unified approach. A member of the board of directors for Verastem Oncology (VSTM) and Oncopeptides AB (ONCO).

Robert Weinberg Ph.d

Board Member

Christoph Westphal

Founder

Michelle Dipp

Founder

Richard H. Aldrich Mba

Founder and Consultant

Amy C Cavers

Chief Engagement and Innovation

Amy C Cavers is a Chief Engagement and Innovation at VERASTEM, INC.. She has worked as VP:Marketing at CELGENE CORP and Senior VP:Strategic Engagement & Alignment at VERASTEM, INC.. Amy attended University of Arizona.

Michael G. Kauffman

Board Member

John H. Johnson

Board Member

Eric K. Rowinsky

Board Member

Lesley Solomon

Board Member

Do you work at Verastem Oncology?

Does leadership effectively guide Verastem Oncology toward its goals?

Verastem Oncology jobs

Verastem Oncology founders

Name & TitleBio
Robert Weinberg Ph.d

Board Member

Christoph Westphal

Founder

Michelle Dipp

Founder

Richard H. Aldrich Mba

Founder and Consultant

Amy C Cavers

Chief Engagement and Innovation

Amy C Cavers is a Chief Engagement and Innovation at VERASTEM, INC.. She has worked as VP:Marketing at CELGENE CORP and Senior VP:Strategic Engagement & Alignment at VERASTEM, INC.. Amy attended University of Arizona.

Verastem Oncology board members

Name & TitleBio
Brian M. Stuglik

CEO

Brian M. Stuglik's LinkedIn

Global leader in the oncology pharmaceutical sector having successfully developed, acquired and launched several multi-billion dollar oncology brands across multiple tumor types and therapeutic approaches. Over 3 decades of experience in US and International pharmaceutical development, product strategy, commercialization and business development; and, has cultivated an extensive network with specialists and companies developing new treatment approaches for patients living with cancer.

Recently, founded Proventus Health Solutions, a company specializing in helping oncology biotech companies create greater value by integrating development and commercial considerations into a unified approach. A member of the board of directors for Verastem Oncology (VSTM) and Oncopeptides AB (ONCO).

Robert Weinberg Ph.d

Board Member

Richard H. Aldrich Mba

Founder and Consultant

Michael G. Kauffman

Board Member

John H. Johnson

Board Member

Eric K. Rowinsky

Board Member

Lesley Solomon

Board Member

Michelle Robertson

Board Member

Paul A. Bunn

Board Member

One Renegade Cell

Board Member

Verastem Oncology executives FAQs

Zippia gives an in-depth look into the details of Verastem Oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Verastem Oncology. The employee data is based on information from people who have self-reported their past or current employments at Verastem Oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Verastem Oncology. The data presented on this page does not represent the view of Verastem Oncology and its employees or that of Zippia.

Verastem Oncology may also be known as or be related to VERASTEM INC., Verastem, Verastem Inc, Verastem Oncology and Verastem, Inc.